In Europe, the recent surveillance shows more than 10,600 reported cases of monkeypox across 36 countries, based on the latest data from the European Centre for Disease Prevention and Control and the WHO regional office for Europe.
This mirrors the European surveillance system, which confirms 9,281 cases as of July 19, with 9,276 of those having laboratory confirmation. In areas where regional breakdowns exist, about 150 cases were traced to the West African region.
The first symptoms appeared as early as April 3, 2022, and the data indicate that most patients fall within the 31 to 40 age group, accounting for roughly 42 percent, with a strong male predominance at 99.5 percent. Among cases with known serostatus, about 38 percent tested seropositive. The most common clinical manifestations are a widespread rash observed in 94.5 percent of cases, along with systemic symptoms such as fever, fatigue, muscle aches, vomiting, diarrhea, chills, sore throat, and headache in a significant portion of patients.
Hospitalization affected about 256 individuals, representing 8.1 percent of cases, with 114 requiring clinical care. There was one reported intensive care admission, and no deaths were recorded in the dataset. A subset of cases involved healthcare workers, though occupational exposure details were not consistently documented.